Versant invests again in obesity, this time backing Helicore Biopharma
Enhertu, with new FDA OK, set to supplant chemo in HER2-low breast cancer
Takeda regains home rights to phase 3-stage depression drug from Neurocrine
Stopwatch starts on reviews of GSK's long-acting asthma drug
*please scroll down for all the latest news*
